XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit​
Common Stock Including Additional Paid in Capital
Beginning balance (in shares) at Dec. 31, 2023   181,364,180        
Beginning balance at Dec. 31, 2023 $ 3,145,305 $ 1,815 $ 6,611,237 $ 1,428 $ (3,469,175)  
Increase (Decrease) in Stockholders' Equity            
Exercise of common stock options (in shares)   71,537        
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures (44) $ 17 (61)      
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures   1,792,087        
Issuance of common stock to fund the Company's 401(k) match (in shares)   617,384        
Issuance of common stock to fund the Company's 401(k) match 40,550 $ 6 40,544      
Employee Benefits and Share-Based Compensation 60,370   60,370      
Net loss (110,228)       (110,228)  
Other comprehensive income (loss) (1,927)     (1,927)    
Ending balance (in shares) at Mar. 31, 2024   183,845,188        
Ending balance at Mar. 31, 2024 $ 3,132,618 $ 1,839 6,710,681 (499) (3,579,403)  
Increase (Decrease) in Stockholders' Equity            
Stock Issued During Period, Value, Stock Options Exercised   $ 1 (1,409)     $ (1,408)
Beginning balance (in shares) at Dec. 31, 2024 185,616,438 185,616,438        
Beginning balance at Dec. 31, 2024 $ 2,402,249 $ 1,857 6,899,368 (944) (4,498,032)  
Increase (Decrease) in Stockholders' Equity            
Exercise of common stock options (in shares)   35,349        
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures (4,223) $ 22 (4,245)      
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures   2,149,825        
Issuance of common stock to fund the Company's 401(k) match (in shares)   793,057        
Issuance of common stock to fund the Company's 401(k) match 43,943 $ 8 43,935      
Employee Benefits and Share-Based Compensation 54,618   54,618      
Net loss (101,215)       (101,215)  
Other comprehensive income (loss) $ 1,957     1,957    
Ending balance (in shares) at Mar. 31, 2025 188,594,669 188,594,669        
Ending balance at Mar. 31, 2025 $ 2,396,907 $ 1,887 6,993,254 $ 1,013 $ (4,599,247)  
Increase (Decrease) in Stockholders' Equity            
Stock Issued During Period, Value, Stock Options Exercised   $ 0 $ (422)     $ (422)